German dementia registry for patients and families
Part of Brain & nervous system, Mental health clinical trials.
This registry is for people with early memory or thinking problems (mild cognitive decline or early dementia). It collects information from patients and their family members over time to help researchers understand different types of dementia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of mild cognitive decline, early dementia, or subjective cognitive decline (eg, Alzheimer's, Parkinson's, or related conditions).
- You need to have had tests (spinal tap or special brain images) that measure proteins like amyloid or tau.
- You must be at least 18 years old and able to give written permission to join.
- If you have a family member joining, they must be closely involved in your daily life and also give their permission.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with mild cognitive impairment or dementia and their family caregivers over time. It aims to learn more about how these conditions progress and how to improve care, especially for those living in Bavaria.
This registry collects information from people with mild cognitive impairment or Alzheimer's disease who are starting a new medication. It helps researchers learn more about these conditions and their treatments over time.
This study creates a registry for people who are using newly approved Alzheimer's medications. It tracks how these treatments work over time and may help researchers learn more about diagnosing and treating Alzheimer's.
This study registry collects health and brain-testing information for people with mild cognitive impairment or early Alzheimer’s dementia. It may help researchers better understand early Alzheimer disease and plan future treatments.
This registry collects information from people with mild cognitive impairment or dementia due to Alzheimer's disease who are being treated with new FDA-approved therapies. The goal is to track how these treatments work in everyday medical practice.
This is a research registry that helps doctors compare how different memory and Alzheimer’s risk groups change over time. It may help researchers learn which people are more likely to develop Alzheimer’s and how to better track early changes.
Hear when a new Dementia Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.